Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Proteome Sciences' Multiplex Phosphoprotein Assay and More


Proteome Sciences this week introduced its SysQuant Assay, a multiplexed mass spec-based assay for quantification of phosphoproteins.

The assay is capable of measuring phosphorylation levels at more than 1,000 sites in a single experiment and can be used in a variety of sample types including cell cultures, xenograft tumor tissue, and patient biopsies, the company said.

Origene this week released its UltraMAB line of antibodies, which are validated using the company's 10K High Density Protein Microarray Technology.

The UltraMAB antibodies are screened against more than 10,000 human proteins to identify the most specific reagents, the company said.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.